NHS Framework Agreement-Branded Medicines - National Proprietary Pharmaceuticals
Details
- Buyer
- NHS England
- Supplier(s)
50 suppliers
- AVENTIS PHARMA LIMITED
- Accord UK Ltd
- Aspen Pharmacare UK Limited
- Aspire Pharma Ltd
- Astellas Pharma LTD.
- Bayer Public Limited Company
- Chiesi Ltd
- CST Pharma Limited
- Day Lewis Medical Ltd
- Dexcel Pharma Ltd
- DRUGSRUS LIMITED
- Eli Lilly and Company Ltd
- Ferring Pharmaceutical
- GEDEON RICHTER (UK) LIMITED
- Gerot Lannach UK Ltd
- Glenmark Pharmaceuticals Europe Ltd
- Ipsen
- Janssen Cilag Ltd
- Kent Pharma Ltd
- Lupin Healthcare (UK) Ltd
- Martindale Pharma
- medac Pharma LLP
- Merck Serono Limited
- Mercury Pharmaceuticals Ltd
- Morningside Pharmaceuticals Ltd
- Mylan
- Napp Pharmaceuticals Ltd
- Neuraxpharm UK Ltd
- Nordic Pharma Ltd
- Norgine Pharmaceuticals Limited
- Novartis Pharmaceutical UK Ltd
- Orifarm UK
- Otsuka Pharmaceuticals UK Limited
- Pfizer Liimted
- Pharmasure
- Qdem Pharmaceuticals
- Recordati Rare Diseases UK Ltd
- Ridge Pharma
- ROVI BIOTECH LIMITED
- Sandoz
- Selective Supplies Ltd
- Synchrony
- Takeda UK Limited
- Tetris Pharma Lts
- Teva UK Ltd
- Theramex HQ UK Ltd
- Tillomed Laboratories Ltd
- Wockhardt UK Limited
- Xiromed
- Zentiva Pharma UK Ltd
- Value
- £304,504,000
- Duration
- 2 years
- Topic
- Pharmaceutical products
- Published
- 6 April 2023
- Source
- uk:contracts_finder
Tender description
NHS Framework Agreement for Branded Medicines - National Proprietary Pharmaceuticals Offer reference number: CM/PHR/22/5675 CM/PHR/22/5675/01 - NHS Framework Agreement for Branded Medicines - National Category Tender Lot 1. Period of framework: 1 May 2023 to 30 April 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/22/5675/02 - NHS Framework Agreement for Branded Medicines - National Tender Lot 2. Period of framework: 1 May 2023 to 30 April 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months
Timeline
- Completed: Award published6 April 2023Current notice
- Completed: Award date1 May 2023
- Completed: Contract expiry date30 April 2025
About the buyer
NHS England runs the NHS in England, and buys as a central healthcare organisation with its own team of procurement professionals. Much of this procurement flows through framework agreements and the Crown Commercial Service. Seven regional teams support the commissioning of healthcare services across the country. The central commercial function that develops procurement strategy for the whole NHS sits here.
Clinical services are commissioned directly or through the Provider Selection Regime.
Over the past 5 years, most of NHS England's contract awards have been in education and training, health and social work, and IT services.
Decision makers
Connect with the people behind this procurement.
| Contact name | Job title | Phone number | Work email |
|---|---|---|---|
| Head of Procurement | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Commercial Director | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Procurement Manager | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Category Lead | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Senior Buyer | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Contracts Manager | +44 •••• •••••• | ••••••••@nhs-england.gov |
12 similar open tenders
See more open tenders related to Pharmaceutical products.
- Open tender
Generic Drugs - Oral Liquids
- Open tender
Injection Equipment Paraphernalia
- Open tender
IMP Manufacture, Labelling and Packaging DPS
- Open tender
CPH037 - Enhanced Services (Pharmacies)
- Open tender
Potassium iodide tablets 2024-2026
Related buyers
Buyers similar to NHS England.
- 509£244.2m
- 445£1.5bn
- 405£112.4m
- 400£2.0bn
- 324£1.2bn
- 322£24.6bn
- 291£1.6bn
- 246£3.1bn
- 155£125.4m
- 150£1.0bn
Finding public sector work shouldn't be hard
Make your next tender search effortless with Stotles. Set up alerts, find decision maker contacts and never miss a good-fit opportunity again.